Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Aileron Therapeutics' ALRN-6924 shows preclinical activity against acute radiation injury

Oct. 8, 2021

New 5-HT2 receptor agonists identified

Oct. 6, 2021

NIDA agrees to screen Initiator Pharma's preclinical assets for anti-addictive properties

Sep. 20, 2021

MC-100093 attenuates cocaine relapse in rats

Sep. 16, 2021

LB-100 blocks METH-induced drug-seeking/taking behavior in mice

Sep. 8, 2021

Camino studies SBP-9330 in first-in-human trial for smoking cessation

Aug. 26, 2021

FDA clears IND application for DCR-AUD

July 30, 2021

Opiant reports topline data from confirmatory PK study of OPNT-003 for opioid overdose

July 7, 2021

New target identified for acetaminophen liver injury

June 14, 2021

NIDA studies TRV-734 in phase II for opioid use disorder

May 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026